Nvidia's $10.
4 Million Bet on AI Powered Medicine Nvidia's significant investment in Generate Biomedicines, a clinical stage biotech company using artificial intelligence to develop novel medicines, has sent shockwaves through the tech industry.
The deal, worth $10. 4 million, is modest in size but carries substantial implications for both Nvidia and Generate Biomedicines.